Literature DB >> 14532900

New concepts in vulvodynia.

Libby Edwards1.   

Abstract

Vulvodynia is chronic vulvar burning/pain without clear medical findings. The etiology of vulvodynia is unknown and health care professionals should thoroughly rule out specific, treatable causes or factors such as dermatoses or group B Streptococcus infections. Vulvodynia is divided into 2 classes: vulvar vestibulitis syndrome is vestibule-restricted burning/pain and is elicited by touch; dysesthetic vulvodynia is burning/pain not limited to the vestibule and may occur without touch/pressure. After diagnosis, critical factors in successful patient management include education and psychological support/counseling. Unfortunately, clinical trials on potential vulvodynia therapies have been few. Standard therapy includes treating neuropathic pain (eg, tricyclic medications, gabapentin) thought to play a role. Additional therapies may be considered: pelvic floor rehabilitation combined with surface electromyography, interferon alfa, estrogen creams, and surgery. Importantly, any therapy should be accompanied by patient education and psychological support. Because definitive data on effective therapies are lacking, further clinical investigations of treatment options are warranted.

Entities:  

Mesh:

Year:  2003        PMID: 14532900     DOI: 10.1067/s0002-9378(03)00790-7

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  10 in total

1.  Assessment of vulvodynia symptoms in a sample of US women: a prevalence survey with a nested case control study.

Authors:  Lauren D Arnold; Gloria A Bachmann; Raymond Rosen; George G Rhoads
Journal:  Am J Obstet Gynecol       Date:  2007-02       Impact factor: 8.661

Review 2.  Gynecologic management of neuropathic pain.

Authors:  Frank F Tu; Kevin M Hellman; Miroslav M Backonja
Journal:  Am J Obstet Gynecol       Date:  2011-05-12       Impact factor: 8.661

3.  Examining vaginal and vulvar health and sexual dysfunction in patients with interstitial cystitis (UNICORN-1 study).

Authors:  Nobuo Okui; Machiko Okui; Marco Gambacciani
Journal:  Int Urogynecol J       Date:  2022-05-11       Impact factor: 1.932

4.  Optimal management of chronic cyclical pelvic pain: an evidence-based and pragmatic approach.

Authors:  Ha Ryun Won; Jason Abbott
Journal:  Int J Womens Health       Date:  2010-08-20

5.  Pityriasis rosea-like drug eruption due to nortriptyline in a patient with vulvodynia.

Authors:  Haider K Bangash; Tunisia Finch; Vesna Petronic-Rosic; Aisha Sethi; Emily Abramsohn; Stacy Tessler Lindau
Journal:  J Low Genit Tract Dis       Date:  2013-04       Impact factor: 1.925

6.  Chronic vulvar and other gynecologic pain: prevalence and characteristics in a self-reported survey.

Authors:  Gloria A Bachmann; Raymond Rosen; Lauren Denise Arnold; Irina Burd; George G Rhoads; Sandra R Leiblum; Nancy Avis
Journal:  J Reprod Med       Date:  2006-01       Impact factor: 0.142

7.  Painful bladder syndrome/interstitial cystitis and vulvodynia: a clinical correlation.

Authors:  Kenneth Peters; Benjamin Girdler; Donna Carrico; Ibrahim Ibrahim; Ananias Diokno
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-11-24

8.  Effects of vulvodynia on quality of life.

Authors:  Maya Ponte; Erika Klemperer; Anju Sahay; Mary-Margaret Chren
Journal:  J Am Acad Dermatol       Date:  2008-11-20       Impact factor: 11.527

9.  Clinicians' Perceptions of Norwegian Women's Experiences of Infertility Diseases.

Authors:  Alexandra Fernandes; Lotte-Lise Skotnes; Maria Major; Pedro Fontes Falcão
Journal:  Int J Environ Res Public Health       Date:  2020-02-05       Impact factor: 3.390

10.  Neonatal vaginal irritation results in long-term visceral and somatic hypersensitivity and increased hypothalamic-pituitary-adrenal axis output in female mice.

Authors:  Angela N Pierce; Zhen Zhang; Isabella M Fuentes; Ruipeng Wang; Janelle M Ryals; Julie A Christianson
Journal:  Pain       Date:  2015-10       Impact factor: 7.926

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.